BPA Call HT001414A0004-HT001417F0150
Award Date 6/30/17
Potential Completion Date 3/31/18
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency to the prime contractor TDS Med, Inc., a self-certified small disadvantaged business. The $150,000 firm fixed-price contract is to provide pharmaceutical products including blood products, oncological pharmaceuticals, injectables, orals, and medical inhalations to address shortages. The contract has a completion date of September 30, 2017. TDS Med, Inc. holds an active $2 million BPA with...
- This is a Firm Fixed Price BPA Call contract awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business. The $300,000 contract is for the supply of shortage pharmaceutical items, including pharmaceuticals, blood products, medical inhalations, and injectables, to support the Bureau of Medicine and Surgery's requirements. This award is a task order issued under a $2 million Blanket Purchase Agreement (BPA) awarded to TDS Med, Inc. by the DHA in...
- The U.S. Defense Health Agency awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call worth up to $300,000 to TDS Med, Inc., a self-certified small disadvantaged business, to provide pharmaceuticals, blood products, and other medical items including injectables, orals, and inhalations. This BPA was established in September 2019 and has a 5-year ordering period. TDS Med, Inc. has previously provided COVID-19 response and pharmaceutical shortage support to the Department of Defense and...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Defense's Bureau of Medicine and Surgery to TDS Med, Inc., a self-certified small disadvantaged business, to provide various pharmaceutical products. The $250,000 award has an ultimate completion date of September 30, 2015. TDS Med, Inc. has provided pharmaceutical products and medical supplies in support of COVID-19 response efforts and to address shortages for the Defense Health Agency and...
- This is a firm fixed-price BPA call awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business, to provide shortage pharmaceuticals, blood products, oncological products, injectables, orals, and medical inhalations. The $264,000 contract has an ultimate completion date of September 30, 2019. TDS Med, Inc. is an active federal contractor, holding a $2 million Blanket Purchase Agreement with the DHA to provide pharmaceutical products and supplies...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) award to TDS Med, Inc., a small disadvantaged business, by the Defense Health Agency (DHA) for pharmaceutical products. The contract has a ceiling value of $150,000.00 and a period of performance through September 30, 2015. This BPA is part of a larger $2 million IDV (Indefinite Delivery Vehicle) contract awarded to TDS Med, Inc. in September 2019 to provide shortage pharmaceuticals, blood products, medical inhalations, injectables, and...
- The U.S. Defense Health Agency (DHA) awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to TDS Med, Inc., a self-certified small disadvantaged business, to provide shortage pharmaceuticals for the Walter Reed National Military Medical Center (WRNMMC). The contract, valued at $300,000.00, has an ultimate completion date of September 30, 2016. This award is under a larger $2 million BPA with TDS Med, Inc. that was originally awarded by DHA in September 2019 to provide...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business, to provide pharmaceutical supplies and drugs for the Walter Reed National Military Medical Center (WRNMMC). The $300,000 contract has an ultimate completion date of September 30, 2015 and was awarded on June 30, 2015. TDS Med, Inc. is an active federal contractor that has previously supported COVID-19 response...
- This firm-fixed-price purchase order was awarded by the Department of the Army Medical Command to TDS Med, Inc., a self-certified small disadvantaged business, on August 21, 2018. The $139,501.81 contract is for the ratification of UA-RHCO-P-111, which involves the provision of emergency drug supply solutions, including shortage pharmaceuticals, blood products, medical inhalations, injectables, and other relevant pharmaceutical products to support federal agencies. TDS Med, Inc. has previously...
- This federal contract award, valued at $160,912.99, was issued by the Medical Supply Chain, a branch of the Defense Logistics Agency (DLA), to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...